Multifrequency VLBA observations of two compact symmetric objects

In this thesis the results of the multifrequency VLBA observations of the GPS 1944+5448 and the HFP J0111+3906 are presented. They are compact objects smaller than about 100 pc, completely embedded in the host galaxy. The availability of multi-epoch VLBI observations spanning more than 10 years, allowed us to compute the hot spot advance speed in order to obtain the kinematic age of both sources. Both radio sources are young, in agreement with the idea that they are in an early evolutionary stage. The spectral analysis of each source component, such as the lobes, the hot spots, the core and the jets, making a comparison with the theoretical ones is described. In addition the physical parameters derived from VLBA images as the magnetic field, the luminosity, the energy and the ambient medium density of both sources are discussed.

Inverse and regular phenyl-azole ligands for luminescent Iridium(III) complexes

In the modern society, light is mostly powered by electricity which lead to a significant increase of the global energy consumption. In order to reduce it, different kinds of electric lamps have been developed over the years; it is now accepted that phosphorescence-based OLEDs offer many advantages over existing light technologies. Iridium complexes are considered excellent candidates for bright materials by virtue of the possibility to easily tune the wavelength of the emitted radiation, by appropriate modifications of the nature of the ligands. It is important to note that the synthesis of Ir(III) blue-emitting complexes is a very challenging goal, because of wide HOMO-LUMO gaps needed for produce a deep blue emission. During my thesis I planned the synthesis of two different series of new Ir(III) heteroleptic complexes, the C and the N series, using cyclometalating ligands containing an increasing number of nitrogens in inverse and regular position. I successfully performed in the synthesis of the required four ligands, i.e. 1-methyl-4-phenyl-1H-imidazole (2), 4-phenyl-1-methyl-1,2,3-triazole (3), 1-phenyl-1H-1,2,3-triazole (6) and 1-phenyl-1H-tetrazole (7), that differ in the number of nitrogens present in the heterocyclic ring and in the position of the phenyl ring. Therefore the cyclometalation of the obtained ligands to get the corresponding Ir(III)-complexes was attempted. I succeeded in the synthesis of two Ir(III)-complexes of the C series, and I carried out various attempts to set up the appropriate reaction conditions to get the remaining desired derivatives. The work is still in progress, and once all the desired complexes will be synthesized and characterized, a correlation between their structure and their emitting properties could be formulated analysing and comparing the photophysical data of the real compounds.

Parallel recusive algorithms for inverse discrete Legendre transform and inverse discrete Laguerre transform

This paper presents parallel recursive algorithms for the computation of the inverse discrete Legendre transform (DPT) and the inverse discrete Laguerre transform (IDLT). These recursive algorithms are derived using Clenshaw's recurrence formula, and they are implemented with a set of parallel digital filters with time-varying coefficients.

Equivariant inverse spectral theory and toric orbifolds

Let O-2n be a symplectic toric orbifold with a fixed T-n-action and with a tonic Kahler metric g. In [10] we explored whether, when O is a manifold, the equivariant spectrum of the Laplace Delta(g) operator on C-infinity(O) determines O up to symplectomorphism. In the setting of tonic orbifolds we shmilicantly improve upon our previous results and show that a generic tone orbifold is determined by its equivariant spectrum, up to two possibilities. This involves developing the asymptotic expansion of the heat trace on an orbifold in the presence of an isometry. We also show that the equivariant spectrum determines whether the toric Kahler metric has constant scalar curvature. (C) 2012 Elsevier Inc. All rights reserved.

Mechanisms of osteoclastogenesis inhibition by a novel class of biphenyl-type cannabinoid CB(2) receptor inverse agonists

The cannabinoid CB(2) receptor is known to modulate osteoclast function by poorly understood mechanisms. Here, we report that the natural biphenyl neolignan 4'-O-methylhonokiol (MH) is a CB(2) receptor-selective antiosteoclastogenic lead structure (K(i) < 50 nM). Intriguingly, MH triggers a simultaneous G(i) inverse agonist response and a strong CB(2) receptor-dependent increase in intracellular calcium. The most active inverse agonists from a library of MH derivatives inhibited osteoclastogenesis in RANK ligand-stimulated RAW264.7 cells and primary human macrophages. Moreover, these ligands potently inhibited the osteoclastogenic action of endocannabinoids. Our data show that CB(2) receptor-mediated cAMP formation, but not intracellular calcium, is crucially involved in the regulation of osteoclastogenesis, primarily by inhibiting macrophage chemotaxis and TNF-α expression. MH is an easily accessible CB(2) receptor-selective scaffold that exhibits a novel type of functional heterogeneity.

Lead discovery, chemistry optimization, and biological evaluation studies of novel biamide derivatives as CB2 receptor inverse agonists and osteoclast inhibitors

N,N'-((4-(Dimethylamino)phenyl)methylene)bis(2-phenylacetamide) was discovered by using 3D pharmacophore database searches and was biologically confirmed as a new class of CB(2) inverse agonists. Subsequently, 52 derivatives were designed and synthesized through lead chemistry optimization by modifying the rings A-C and the core structure in further SAR studies. Five compounds were developed and also confirmed as CB(2) inverse agonists with the highest CB(2) binding affinity (CB(2)K(i) of 22-85 nM, EC(50) of 4-28 nM) and best selectivity (CB(1)/CB(2) of 235- to 909-fold). Furthermore, osteoclastogenesis bioassay indicated that PAM compounds showed great inhibition of osteoclast formation. Especially, compound 26 showed 72% inhibition activity even at the low concentration of 0.1 μM. The cytotoxicity assay suggested that the inhibition of PAM compounds on osteoclastogenesis did not result from its cytotoxicity. Therefore, these PAM derivatives could be used as potential leads for the development of a new type of antiosteoporosis agent.